ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0897

APECED Disease Reorganizes The B Cell Compartment Toward Alternatively Activated Subsets

william Galbavy, Hyunjin Kim, Brian Klotz, Marine Malbec, Carley Tasker, Eva Conde, Andrea Vecchione, Seblewongel Asrat, Benjamin Daniel, Weikeat Lim, Andre Limnander and Jamie Orengo, Regeneron, Tarrytown, NY

Meeting: ACR Convergence 2025

Keywords: Autoantibody(ies), autoimmune diseases, B-Cell Targets, B-Lymphocyte, immunology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (0897–0915) B Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Autoimmune PolyEndocrinopathy Candidiasis Ectodermal Dystrophy (APECED) is a rare syndrome of multi-organ autoimmunity driven by the presence of self-reactive T cells and autoantibodies caused by mutations in the gene Autoimmune regulator (Aire). Compared to the well-defined role of Aire in establishing and maintaining T cell central tolerance by helping medullary thymic epithelial cells eliminate self-reactive T cells, less is known about how Aire deficiency in APECED impacts B cells and causes a breakdown in peripheral B cell tolerance.

Methods: We performed single-cell sequencing analyses, flow cytometry, and autoantibody profiling of PBMCs and serum of 10 APECED patients and 10 controls.

Results: We found robust changes in the B cell compartment of APECED patients relative to that of healthy donors, with a substantially lower percentage of naïve B cells and significant increases in antigen-experienced B cell phenotypes. Among these changes seen by scRNAseq compositional analysis were increases in Memory B cells (TACI+ CD27+), and Atypical B cells (CD21lo CD11c+ Tbet+). Serum autoantibody profiling with an array of ~23,000 proteins uncovered >200 APECED associated IgG autoantibody varieties, including to type I IFN, IL17, key enzymes including the cytochrome P450 family, neurotransmitter associated proteins, and others. The Atypical B cell subset in patients was found to be especially correlated to levels of IgG autoantibodies, and had a molecular signature enriched in antigen presentation and B cell activation genes.

Conclusion: These results demonstrate that the B cell compartment is altered in APECED patients relative to healthy controls, with a marked increase in multiple activated B cell subsets that may contribute to autoantibody production and disease manifestations.


Disclosures: w. Galbavy: Regeneron, 3, 11; H. Kim: Regeneron, 3, 11; B. Klotz: Regeneron, 3, 11; M. Malbec: Regeneron, 3, 11; C. Tasker: Regeneron, 3, 11; E. Conde: Regeneron, 3, 11; A. Vecchione: Regeneron, 3, 11; S. Asrat: Regeneron, 3, 11; B. Daniel: Regeneron, 3, 11; W. Lim: Regeneron, 3, 11; A. Limnander: Regeneron, 3, 11; J. Orengo: Regeneron, 3, 3, 11, 11.

To cite this abstract in AMA style:

Galbavy w, Kim H, Klotz B, Malbec M, Tasker C, Conde E, Vecchione A, Asrat S, Daniel B, Lim W, Limnander A, Orengo J. APECED Disease Reorganizes The B Cell Compartment Toward Alternatively Activated Subsets [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/apeced-disease-reorganizes-the-b-cell-compartment-toward-alternatively-activated-subsets/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/apeced-disease-reorganizes-the-b-cell-compartment-toward-alternatively-activated-subsets/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology